NEW YORK, NY / ACCESSWIRE / October 20, 2020 / Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against clinical-stage biotech company Eidos Therapeutics. (NASDAQ:EIDX).
If you currently own shares of Eidos and want to receive additional information and protect your investments free of charge, please contact David J. Schwartz using the toll free number (800) 321-0476 or via email at [email protected].
About the Firm
Labaton Sucharow LLP is one of the world's leading complex litigation firms representing clients in securities, antitrust, corporate governance and shareholder rights, and consumer cybersecurity and data privacy litigation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at http://www.labaton.com.
Contact:
David J. Schwartz
(800) 321-0476
[email protected]
SOURCE: Labaton Sucharow LLP